Quarterly report [Sections 13 or 15(d)]

Stockholders' equity

v3.25.1
Stockholders' equity
 3 Months Ended
Mar. 31, 2025
Stockholders' equity  
Stockholders' equity

Note 12 — Stockholders’ equity

On April 8, 2022 the Company entered into a sales agreement with TD Cowen (the “Sales Agreement”), as amended pursuant to amendment no. 1 to Sales Agreement dated April 18, 2025 (together the “Agreement”), under which we may from time to time issue and sell American Depositary Shares (ADSs) representing our ordinary shares through TD Cowen in “at-the-market” offerings (“ATM”) for an aggregate offering price of up to $200 million. In the three months ended March 31, 2025 the Company sold 1,327,027 ADSs under the Agreement representing 7,962,162 ordinary shares (including 710,000 ADSs sold on March 31, 2025 representing 4,260,000 ordinary shares issued on April 1, 2025) resulting in net proceeds to the Company of $259,477 after deducting commissions payable under the Agreement and issuance costs. As of March 31, 2025, approximately $155,952,137 remained available for sale under the Agreement.

​

​